Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL682572 | 0.96 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL8874684 | 0.89 | AGTR1 (0.44) | AGTR1AGTR2 | |
| SCHEMBL7302661 | 0.88 | PPARG (0.44) | AGTR1AGTR2 | |
| SCHEMBL7313296 | 0.88 | AGTR1 (0.46) | AGTR1AGTR2 | |
| SCHEMBL7311921 | 0.86 | AGTR1 (0.41) | AGTR1 | |
| SCHEMBL7309361 | 0.84 | PPARG (0.50) | AGTR1AGTR2 | |
| SCHEMBL7312115 | 0.83 | AGTR1 (0.49) | AGTR1AGTR2 | |
| SCHEMBL7301773 | 0.81 | AGTR1 (0.48) | AGTR1AGTR2 | |
| SCHEMBL7301596 | 0.81 | AGTR1 (0.46) | AGTR1AGTR2 | |
| Ammonia Solution, Strong SCHEMBL9312909 | 0.80 | PPARG (0.56) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| EP-0502314-A1 | Benzimidazol, medicaments containing them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1992-09-09 | — | — | EP | disclosed |